MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

Начало・Списък с акции・Pliant Therapeutics Inc

Search

Pliant Therapeutics Inc

Отворен

1.27 -0.78

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.25

Максимум

1.3

Ключови измерители
By Trading Economics
Приходи	2.7M -24M
EPS	-0.354
Служители	49
EBITDA	-5.3M -28M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+106.98% upside

Дивиденти
By Dow Jones
Следващи печалби	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-624K 80M
Предишно отваряне	2.05
Предишно затваряне	1.27

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

1.43 / 1.6 Подкрепа & съпротива

Pliant Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.04.2026 г., 23:49 ч. UTC

Значими събития в новините

New Zealand 1Q Inflation Higher Than Expected

20.04.2026 г., 23:10 ч. UTC

Горещи акции

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20.04.2026 г., 22:53 ч. UTC

Значими двигатели на пазара

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20.04.2026 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20.04.2026 г., 23:44 ч. UTC

Пазарно говорене

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20.04.2026 г., 23:39 ч. UTC

Пазарно говорене

Rio Tinto Posts Strong Start to Year -- Market Talk

20.04.2026 г., 23:30 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.04.2026 г., 23:30 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.04.2026 г., 23:30 ч. UTC

Пазарно говорене

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20.04.2026 г., 23:09 ч. UTC

Пазарно говорене

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20.04.2026 г., 22:31 ч. UTC

Придобивния, сливания и поглъщания

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20.04.2026 г., 22:26 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Aims for Acquisition to Be Completed by End-2026

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says Acquisition Would Be for A$175 Million

20.04.2026 г., 22:24 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20.04.2026 г., 22:15 ч. UTC

Придобивния, сливания и поглъщания

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20.04.2026 г., 22:01 ч. UTC

Придобивния, сливания и поглъщания

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20.04.2026 г., 21:38 ч. UTC

Пазарно говорене

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20.04.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20.04.2026 г., 21:24 ч. UTC

Пазарно говорене

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20.04.2026 г., 21:24 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.04.2026 г., 21:13 ч. UTC

Печалби

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20.04.2026 г., 21:10 ч. UTC

Печалби

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20.04.2026 г., 21:09 ч. UTC

Печалби

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20.04.2026 г., 21:08 ч. UTC

Печалби

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20.04.2026 г., 21:07 ч. UTC

Печалби

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20.04.2026 г., 21:05 ч. UTC

Печалби

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20.04.2026 г., 21:05 ч. UTC

Печалби

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Сравнение с други в отрасъла

Ценова промяна

Pliant Therapeutics Inc Прогноза

Ценова цел

By TipRanks

106.98% нагоре

12-месечна прогноза

Среден 2.67 USD 106.98%

Висок 3 USD

Нисък 2 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Pliant Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

2

Купи

3

Задържане

0

Продай

Според 5 анализатори, дали борсови рейтинги на Pliant Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

1.43 / 1.6Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Други акции от сектора

MDT

Medtronic PLC

82.53

A

Agilent Technologies Inc

122

VEEV

Veeva Systems Inc

167.85

HQY

HealthEquity Inc

83.95

NEOG

Neogen Corp

9.42

Live chat